Sonic Healthcare (ASX:SHL) has announced an agreement to invest $17.8M to acquire a 19.99% shareholding in Microba Life Sciences (ASX:MAP).

Sonic also says it?s seeking to acquire options for an additional 5% equity position, subject to approval by Microba?s shareholders.

Sonic and Microba will exclusively deliver Microba?s microbiome testing technology into Germany, the UK and Belgium, along with non-exclusive distribution into Sonic?s broader network including Australia, Switzerland, the United States and New Zealand.

Microba says it has world-leading technology for measuring the human gut microbiome, and creates novel therapeutics for major chronic diseases.